These findings suggest potential benefit for patients with existing liver damage, not just those seeking weight reduction
For patients unable to access or tolerate Ozempic, other GLP-1 receptor agonists may be considered, including dulaglutide, liraglutide, or exenatide, though availability varies
116 RajanKBWeuveJBarnesLLMcAninchEAWilsonRSEvansDA
Mild symptoms such as localised itching, redness, or a small rash should be discussed with a healthcare professional as soon as possible
You know, areas that I'd focus on, still in metabolic disease but looking at things like fatty liver disease, you know, high cholesterol and then still in inflammatory disease, there's a lot of what we call unmet need, you know, a lot of folks that have psoriasis, that have, you know, various types of arthritis
One small study (12 patients) showed a 58% response rate for knee pain relief